Ariosa Fights Sales Ban, Says It's Not An Illumina Competitor
Ariosa and Illumina sparred in California federal court Friday over whether Ariosa should be barred from selling its prenatal tests after a jury found it infringed two patents and owed Illumina $27 million, with...To view the full article, register now.
Already a subscriber? Click here to view full article